Abstract
The effect of the COVID-19 vaccination as an individual-based preventive measure on mental health is largely unclear in the literature. The authors report a preliminary finding on whether vaccination effectively improves mental health among employees in Japan based on a prospective study (E-COCO-J). Of the total sample (N=948), 105 (11.1%) were vaccinated at least once at the follow-up survey (June 2021). There was no significant effect of vaccination on the change of psychological distress at baseline (February 2021) and follow-up (June 2021), after adjusting for gender, age, marital status, education, chronic disease, company size, industry, and occupation (healthcare workers or non-HCWs). Providing continuous mental health care for employees is important in an early vaccination phase.
Competing Interest Statement
NK reports grants from SB AtWork Corp, Fujitsu Ltd, and TAK Ltd, personal fees from the Occupational Health Foundation, SB AtWork Corp, RIKEN, Japan Aerospace Exploration Agency (JAXA), Japan Dental Association, Sekisui Chemicals, Junpukai Health Care Center, Osaka Chamber of Commerce and Industry, outside the submitted work.
Funding Statement
Funding/Support: This work was supported by the 2021 Health, Labour and Welfare Policy Research Grants, The Japan Ministry of Health, Labour, and Welfare and an internal fund of the Department of Mental Health, Graduate School of Medicine, The University of Tokyo.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval of the research protocol: This study was approved by the Research Ethics Committee of the Graduate School of Medicine/Faculty of Medicine, The University of Tokyo, No. 10856-(2)(3)(4)(5). Informed consent: Online informed consent was obtained from all participants with full disclosure and explanation of the purpose and procedures of this study. We explained that their participation was voluntary, and they can withdraw consent for any reason, simply by not completing the questionnaire.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
nasasaki-tky{at}umin.ac.jp
urk{at}ohs.adm.u-tokyo.ac.jp
ktsuno-tky{at}umin.ac.jp
kouima-tky{at}umin.ac.jp
Data Availability
Data availability statement: The data that support the findings of this study are available from the corresponding author, NK, upon reasonable request.
